|
Market Closed -
Other stock markets
|
After hours 19:55:01 | |||
| 44.20 USD | -0.58% |
|
44.50 | +0.68% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating | MT |
| Market Cap | 65.7B 57.71B 53.17B 49.71B 93.24B 6,199B 94.95B 638B 247B 3,056B 247B 241B 10,620B | P/E 2026 * |
16.2x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 72.86B 64B 58.96B 55.13B 103B 6,875B 105B 707B 274B 3,389B 274B 268B 11,777B | EV / Sales 2026 * |
3.37x | EV / Sales 2027 * | 2.99x |
| Free-Float |
84.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.68% | ||
| 1 week | -2.41% | ||
| Current month | -8.51% | ||
| 1 month | -23.50% | ||
| 3 months | -36.66% | ||
| 6 months | -54.02% | ||
| Current year | -53.64% |
| 1 week | 43.89 |  | 45.83 |
| 1 month | 43.89 | | 53.2 |
| Current year | 43.89 | | 100.9 |
| 1 year | 43.89 | | 109.5 |
| 3 years | 43.89 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 2025-06-29 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 2009-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 74 | 2014-02-28 |
Ellen Zane
BRD | Director/Board Member | 74 | 2016-04-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-27 | Don | Chief Executive Officer | -386,755 | 0.0261% | ||
| 05-19 | Buy | Director | 3,580 | 0.0002% | ||
| 05-19 | Buy | Director | 1,770 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -2.41% | -57.62% | -18.10% | 66.08B | |
| +2.75% | +8.85% | +23.16% | -3.52% | 183B | |
| -0.53% | -1.74% | -23.38% | +22.13% | 142B | |
| +2.30% | +9.05% | -3.88% | -18.88% | 134B | |
| +0.07% | +2.70% | +16.56% | -0.69% | 51.63B | |
| +0.50% | -0.09% | -26.76% | -32.86% | 43.38B | |
| +2.95% | +6.65% | +14.24% | +13.47% | 37.18B | |
| +2.09% | +6.03% | +7.68% | +45.05% | 36.25B | |
| +0.09% | +5.44% | -10.74% | -18.64% | 29.51B | |
| +1.07% | +5.29% | -23.00% | -7.74% | 28.38B | |
| Average | +1.24% | +3.21% | -8.37% | -1.98% | 75.13B | |
| Weighted average by Cap. | +1.45% | +3.28% | -5.17% | -1.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.59B 18.97B 17.47B 16.34B 30.64B 2,037B 31.21B 210B 81.21B 1,004B 81.08B 79.3B 3,490B | 23.36B 20.52B 18.9B 17.67B 33.15B 2,204B 33.76B 227B 87.84B 1,086B 87.71B 85.78B 3,775B |
| Net income | 3.88B 3.41B 3.14B 2.93B 5.5B 366B 5.6B 37.64B 14.58B 180B 14.56B 14.24B 627B | 4.12B 3.62B 3.33B 3.12B 5.85B 389B 5.95B 39.99B 15.49B 192B 15.47B 15.13B 666B |
| Net Debt | 7.16B 6.29B 5.79B 5.42B 10.16B 676B 10.35B 69.51B 26.93B 333B 26.88B 26.29B 1,157B | 4.08B 3.58B 3.3B 3.08B 5.78B 385B 5.89B 39.58B 15.33B 190B 15.31B 14.97B 659B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | US$44.20 | -0.58% | 19,820,589 |
| 26-06-24 | US$44.46 | -2.50% | 20,964,012 |
| 26-06-23 | US$45.60 | +2.86% | 18,696,071 |
| 26-06-22 | US$44.33 | -2.12% | 16,784,721 |
| 26-06-18 | US$45.29 | +0.76% | 30,854,998 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
